Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 14, 2024 |
| PDB ID | UniProt ID ▼ | Title | Descriptor |
|---|---|---|---|
| 8GNH | 8GNH | Complex structure of BD-218 and Spike protein | |
| 8GJN | 8GJN | 17B10 fab in complex with up-RBD of SARS-CoV-2 Spike G614 trimer | |
| 8GJM | 8GJM | 17b10 fab in complex with full-length SARS-CoV-2 Spike G614 trimer | |
| 8GJE | 8GJE | HIV-1 Env subtype C CZA97.12 SOSIP.664 in complex with 3BNC117 Fab | |
| 8GHZ | 8GHZ | Cryo-EM structure of fish immunogloblin M-Fc | |
| 8GHR | 8GHR | Structure of human ENPP1 in complex with variable heavy domain VH27.2 | |
| 8GHP | 8GHP | GUCY2C-ECD bound to anti-GUCY2C-scFv antibody | |
| 8GHK | 8GHK | CryoEM structure of Influenza A virus A/Melbourner/1/1946 (H1N1) hemagglutinin bound to GS10-X6-BE4 Fab | |
| 8GH4 | 8GH4 | Complex of Adam 10 disentegrin cysteine rich domains with human monoclonal antibody | |
| 8GF2 | 8GF2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with antibodies eCR3022.20 and CC12.3 | |
| 8GDR | 8GDR | SARS-Cov2 S protein structure in complex with neutralizing monoclonal antibody 002-S21B10 | |
| 8GC0 | 8GC0 | Crystal structure of PC39-50L, an anti-HIV broadly neutralizing antibody | |
| 8GB8 | 8GB8 | Crystal structure of SARS-CoV-2 BA.2 receptor binding domain in complex with neutralizing antibody 20A7 | |
| 8GB7 | 8GB7 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 20A7 | |
| 8GB6 | 8GB6 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 21B6 | |
| 8GB5 | 8GB5 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9 | |
| 8GAV | 8GAV | Structure of human NDS.3 Fab in complex with influenza virus neuraminidase from A/Darwin/09/2021 (H3N2) | |
| 8GAU | 8GAU | Structure of human NDS.1 Fab and 1G01 Fab in complex with influenza virus neuraminidase from A/Indiana/10/2011 (H3N2v) | |
| 8GAT | 8GAT | Structure of human NDS.1 Fab and 1G01 Fab in complex with influenza virus neuraminidase from A/Indiana/10/2011 (H3N2v), based on consensus cryo-EM map with only Fab 1G01 resolved | |
| 8GAS | 8GAS | vFP48.02 Fab in complex with BG505 DS-SOSIP Env trimer | |
| 8G9Y | 8G9Y | Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 3) | |
| 8G9X | 8G9X | Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 2) | |
| 8G9W | 8G9W | Cryo-EM structure of vFP49.02 Fab in complex with HIV-1 Env BG505 DS-SOSIP.664 (conformation 1) | |
| 8G8W | 8G8W | Molecular mechanism of nucleotide inhibition of human uncoupling protein 1 | |
| 8G8W | 8G8W | Molecular mechanism of nucleotide inhibition of human uncoupling protein 1 | |
| 8G8C | 8G8C | Crystal structure of DH1322.1 Fab in complex with HIV proximal MPER peptide | |
| 8G8A | 8G8A | Crystal structure of DH1317.8 Fab in complex with HIV proximal MPER peptide | |
| 8G85 | 8G85 | vFP52.02 Fab in complex with BG505 DS-SOSIP Env trimer | |
| 8G82 | 8G82 | Vancomycin bound to D-Ala-D-Ser | |
| 8G7C | 8G7C | local refinement of SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound | |
| 8G7B | 8G7B | SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 (local refinement) | |
| 8G7A | 8G7A | SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 (local refinement) | |
| 8G78 | 8G78 | Local refinement of SARS-CoV-2 spike/nanobody mixture complex around NTD | |
| 8G77 | 8G77 | SARS-CoV-2 spike/Nb6 complex | |
| 8G76 | 8G76 | SARS-CoV-2 spike/Nb5 complex | |
| 8G75 | 8G75 | SARS-CoV-2 spike/Nb4 complex with 2 RBDs up and 3 Nb4 bound | |
| 8G74 | 8G74 | SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 | |
| 8G73 | 8G73 | SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 bound at 2.5 A | |
| 8G70 | 8G70 | SARS-CoV-2 spike/nanobody mixture complex | |
| 8G6U | 8G6U | Cryo-EM structure of T/F100 SOSIP.664 HIV-1 Env trimer with LMHS mutations in complex with 8ANC195 and 10-1074 | |
| 8G6I | 8G6I | Coagulation factor VIII bound to a patient-derived anti-C1 domain antibody inhibitor | |
| 8G5H | 8G5H | Native GABA-A receptor from the mouse brain, ortho-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroid | |
| 8G5G | 8G5G | Native GABA-A receptor from the mouse brain, meta-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA, Zolpidem, and endogenous neurosteroid | |
| 8G5F | 8G5F | Native GABA-A receptor from the mouse brain, ortho-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA and allopregnanolone | |
| 8G5B | 8G5B | Influenza A H3N2 X-31 Hemagglutinin in complex with FL-1061 | |
| 8G5A | 8G5A | X-31 hemagglutinin in complex with FL-1061 Fab | |
| 8G4X | 8G4X | Native GABA-A receptor from the mouse brain, meta-alpha1-alpha3-beta2-gamma2 subtype, in complex with GABA and allopregnanolone | |
| 8G4T | 8G4T | Vaccine-elicited human antibody 2C09 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
| 8G4P | 8G4P | Crystal structure of the peanut allergen Ara h 2 bound by two neutralizing antibodies 13T1 and 13T5 | |
| 8G4O | 8G4O | Native GABA-A receptor from the mouse brain, alpha1-beta2-gamma2 subtype, in complex with didesethylflurazepam and endogenous GABA |
